Related Experiment Video
Updated: Jul 1, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Screening for potentially inappropriate prescribing in primary care: Canadian guideline
Emily G McDonald1, Marie-Eve Gagnon2, Derek J Jorgenson3
1Associate Professor at McGill University Health Centre and Director of the Canadian Medication Appropriateness and Deprescribing Network in Montréal, Que.
Objective:
To develop a guideline addressing potentially inappropriate prescribing (PIP) screening in primary care, in accordance with the priority established in Bill C-64 by the Canadian government as part of a strategy for appropriate medication use.
Methods:
The guideline was informed by 2 systematic reviews related to PIP in older adults.
Recommendations:
The guideline recommends that adults aged 65 years or older receive prescription checkups or a related intervention to optimize medication appropriateness. Effective interventions include medication reviews paired with suggestions by a prescriber or pharmacist using a structured approach or set of rules (strong recommendation, moderate-certainty evidence). Second, it is recommended that governments fund prescription checkups or related interventions to optimize medication appropriateness (strong recommendation, moderate-certainty evidence).
Conclusion:
This guideline complements other guidance on how to deprescribe certain medication classes, such as proton pump inhibitors and sedative hypnotics. Interventions should be implemented and funded as part of a pan-Canadian strategy on appropriate medication use, and taken up by provincial, territorial, and federal governments as part of larger strategies to avoid medication-related harms. The effects of interventions should be carefully tracked.
Related Concept Videos
Preventive Healthcare Services
Pre-Procedural Guidelines for Assessing Blood Pressure
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Drug Dosing: Geriatric Patients
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmaceutical Poisoning: Potential Scenarios
